Pathfertility
2 known investors
Path Fertility offers SpermQT, a diagnostic test that measures sperm function rather than just sperm count to help predict pregnancy outcomes and guide fertility treatment decisions such as IUI versus IVF. It serves couples trying to conceive and their fertility providers, and is a brand of Inherent Biosciences, Inc.
BiotechDigital HealthFemTech
Investors Β· 2
Frequently asked questions
- What does Pathfertility do?
- Path Fertility offers SpermQT, a diagnostic test that measures sperm function rather than just sperm count to help predict pregnancy outcomes and guide fertility treatment decisions such as IUI versus IVF. It serves couples trying to conceive and their fertility providers, and is a brand of Inherent Biosciences, Inc.
- Who are Pathfertility's investors?
- Pathfertility's investors include Cadron Capital Partners, Swizzle Ventures.